96 related articles for article (PubMed ID: 7978711)
1. Omeprazole failure in a patient with gastroesophageal reflux disease.
Just R; Katzka DA; Castell DO
Ann Intern Med; 1994 Dec; 121(11):899. PubMed ID: 7978711
[No Abstract] [Full Text] [Related]
2. Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease?
Savarino V; Mela GS; Zentilin P; Celle G
Gastroenterology; 1990 Nov; 99(5):1542-3. PubMed ID: 2210269
[No Abstract] [Full Text] [Related]
3. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole, serum gastrin, and gastric acid suppression.
Gideon RM; Paoletti V; Castell DO
Ann Intern Med; 1995 Feb; 122(3):237-8. PubMed ID: 7810948
[No Abstract] [Full Text] [Related]
5. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Leite LP; Just RJ; Castell DO; Lagerström PO
Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
[TBL] [Abstract][Full Text] [Related]
6. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
Bell NJ; Hunt RH
Gut; 1992 Jan; 33(1):118-24. PubMed ID: 1346769
[TBL] [Abstract][Full Text] [Related]
7. [Gastroesophageal reflux (round table I)].
Caussignac Y; Martin S; Jobin G; Beauchamp G
Union Med Can; 1995 Mar; 124(1):26-31. PubMed ID: 8540149
[No Abstract] [Full Text] [Related]
8. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
9. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole in the treatment of peptic ulcers and gastroesophageal reflux disease.
Cappell MS
N J Med; 1992 Oct; 89(10):762-4. PubMed ID: 1461581
[TBL] [Abstract][Full Text] [Related]
11. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of omeprazole therapy in children with gastroesophageal reflux diseases(GERD)].
Czerwionka-Szaflarska M; Mierzwa G; Kuczyńska R
Pol Merkur Lekarski; 2004 Mar; 16(93):217-9. PubMed ID: 15190593
[TBL] [Abstract][Full Text] [Related]
13. Unresolved issues in gastroesophageal reflux-related ear, nose, and throat problems.
Richter JE; Hicks DM
Am J Gastroenterol; 1997 Dec; 92(12):2143-4. PubMed ID: 9399741
[No Abstract] [Full Text] [Related]
14. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
15. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
16. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
17. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
18. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
Ivanov AN; Iakovenko EP; Iakovenko AV
Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661
[TBL] [Abstract][Full Text] [Related]
19. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
[TBL] [Abstract][Full Text] [Related]
20. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
